Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2021 May 7;5(3):zrab020.
doi: 10.1093/bjsopen/zrab020.

Impact of neoadjuvant chemotherapy on thrombus viability in patients with Wilms tumour and caval extension: systematic review with meta-analysis

T D Boam  1 , M Gabriel  2 , R Shukla  3 , P D Losty  4
Affiliations
Meta-Analysis

Impact of neoadjuvant chemotherapy on thrombus viability in patients with Wilms tumour and caval extension: systematic review with meta-analysis

T D Boam et al. BJS Open. .

Abstract

Background: Inferior vena cava (IVC) tumour thrombus in children with Wilms tumour is typically managed with neoadjuvant chemotherapy with the intention of achieving thrombus regression in order to minimize the risks associated with complex vascular surgery.

Methods: A systematic review of Medline and Embase databases was undertaken to identify all eligible studies with reference to thrombus viability in Wilms tumour index cases with caval/cardiac extension. A meta-analysis of proportions was utilized for pooled thrombus viability data across studies. Logistic regression was used to analyse the relationship between thrombus viability and duration of chemotherapy.

Results: Thirty-five eligible observational studies and case reports met inclusion criteria describing a total of 236 patients with thrombus viability data. The pooled proportion of patients with viable tumour thrombus after neoadjuvant chemotherapy was 0.53 (0.43-0.63). Logistic regression analysis of 54 patients receiving either a standard (4-6 weeks) or extended (more than 6 weeks) course of neoadjuvant chemotherapy resulted in an odds ratio of 3.14 (95 per cent c.i. 0.97 to 10.16), P = 0.056, with extended course therapy trending towards viable tumour thrombus.

Conclusion: Preoperative chemotherapy is successful in achieving non-viability of caval and cardiac thrombi in around 50 per cent of children, without added benefit from extended cycles of neoadjuvant chemotherapy. Risks versus benefits of extirpative vascular surgery must be considered, therefore, for these high-risk patients.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
PRISMA flow diagram
Fig. 2
Fig. 2
Forest plot – proportion meta-analysis of thrombus viability. *Study required additional unpublished information from authors before inclusion
See this image and copyright information in PMC

References

    1. Szavay P, Luithle T, Semler O, Graf N, Fuchs J. Surgery of cavoatrial tumor thrombus in nephroblastoma: a report of the SIOP/GPOH study. Pediatr Blood Cancer 2004;43:40–45 - PubMed
    1. Akyüz C, Emir S, Büyükpamukçu N, Atahan L, Çağlar M, Kutluk T et al. Cavoatrial tumor extension in children with Wilms tumor: a retrospective review of 17 children in a single center. J Pediatr Hematol Oncol 2005;27:267–269 - PubMed
    1. Abdullah Y, Karpelowsky J, Davidson A, Thomas J, Brooks A, Hewitson J et al. Management of nine cases of Wilms’ tumour with intracardiac extension – a single centre experience. J Pediatr Surg 2013;48:394–399 - PubMed
    1. Cox SG, Davidson A, Thomas J, Brooks A, Hewitson J, Numanoglu A et al. Surgical management and outcomes of 12 cases of Wilms tumour with intracardiac extension from a single centre. Pediatr Surg Int 2018;34:227–235 - PubMed
    1. Daum R, Roth H, Zachariou Z. Tumor infiltration of the vena cava in nephroblastoma. Eur J Pediatr Surg 1994;4:16–20 - PubMed